TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 93 filers reported holding TESARO INC in Q4 2013. The put-call ratio across all filers is 2.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,480,000 | +21.6% | 89,202 | +38.6% | 0.03% | +12.5% |
| Q2 2018 | $2,862,000 | -0.1% | 64,354 | +28.3% | 0.02% | -17.2% |
| Q1 2018 | $2,865,000 | -55.5% | 50,140 | -35.5% | 0.03% | -35.6% |
| Q4 2017 | $6,439,000 | -19.6% | 77,701 | +35.8% | 0.04% | -45.8% |
| Q2 2017 | $8,005,000 | +50.5% | 57,233 | +65.5% | 0.08% | +33.9% |
| Q1 2017 | $5,320,000 | +478.9% | 34,576 | +405.9% | 0.06% | +588.9% |
| Q4 2016 | $919,000 | +25.2% | 6,834 | -6.6% | 0.01% | +12.5% |
| Q3 2016 | $734,000 | +189.0% | 7,320 | +15.7% | 0.01% | +100.0% |
| Q3 2015 | $254,000 | +1.2% | 6,329 | +48.5% | 0.00% | 0.0% |
| Q2 2015 | $251,000 | -69.2% | 4,261 | -70.0% | 0.00% | -69.2% |
| Q1 2015 | $815,000 | +68.0% | 14,193 | +8.7% | 0.01% | +85.7% |
| Q4 2014 | $485,000 | -24.5% | 13,053 | -45.2% | 0.01% | -30.0% |
| Q3 2014 | $642,000 | +13.6% | 23,832 | +31.2% | 0.01% | +11.1% |
| Q2 2014 | $565,000 | +11.2% | 18,162 | +1.1% | 0.01% | +12.5% |
| Q4 2013 | $508,000 | – | 17,973 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 2,021,738 | $167,541,000 | 57.29% |
| NEA Management Company, LLC | 10,275,113 | $851,499,000 | 35.27% |
| ORACLE INVESTMENT MANAGEMENT INC | 891,242 | $73,708,000 | 14.64% |
| Eversept Partners, LP | 85,740 | $7,105,274 | 4.09% |
| Copernicus Capital Management, LLC | 64,000 | $5,304,000 | 3.95% |
| Camber Capital Management LP | 850,000 | $70,440,000 | 3.45% |
| BB BIOTECH AG | 1,046,193 | $86,698,000 | 2.44% |
| Cerebellum GP, LLC | 40,479 | $3,354,000 | 2.38% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,300 | $6,406,000 | 2.26% |
| Rock Springs Capital Management LP | 548,500 | $45,454,000 | 2.06% |